<DOC>
<DOCNO>
EP-0001668
</DOCNO>
<TEXT>
<DATE>
19790502
</DATE>
<IPC-CLASSIFICATIONS>
C07C-39/23 C07C-41/00 C07C-45/66 C07C-39/00 C07D-339/06 C07C-45/00 C07D-339/00 C07D-339/08 C07C-67/00 C07C-45/59 C07C-27/00 <main>C07J-13/00</main> C07C-43/00 C07C-41/26 C07C-43/18 C07C-43/23 C07C-43/215 C07C-35/21 C07J-13/00 C07J-9/00 C07C-69/013 C07C-69/00 C07C-35/00 C07C-45/56 
</IPC-CLASSIFICATIONS>
<TITLE>
cyclisation process for preparing 11 beta-axially-substituted steroids.
</TITLE>
<APPLICANT>
akzo nvnl<sep>akzo n.v.<sep>akzo n.v.velperweg 76nl-6824 bm arnhemnl<sep>akzo n.v.<sep>
</APPLICANT>
<INVENTOR>
broess arnoldus isidorus adria<sep>zeelen filippus johannes<sep>broess, arnoldus isidorus adrianus<sep>zeelen, filippus johannes<sep>broess, arnoldus isidorus adrianuspastoor oomenstraat 15nl-5121 en rijennl<sep>zeelen, filippus johannesfloraliastraat 2nl-5384 gp heeschnl<sep>broess, arnoldus isidorus adrianus<sep>zeelen, filippus johannes<sep>broess, arnoldus isidorus adrianuspastoor oomenstraat 15nl-5121 en rijennl<sep>zeelen, filippus johannesfloraliastraat 2nl-5384 gp heeschnl<sep>
</INVENTOR>
<ABSTRACT>
novel and biologically active cyclisation substrates are  disclosed of the formula:    wherein:   (a) r₁ is h or alkyl of one to four carbon atoms;   (b) r₂ is h or alkyl of one to four carbon atoms, with the  proviso that r₁ is h when r₂ is alkyl, and with the  proviso that r₂ is h when r₁ is alkyl;   (c) r₁ is a suitable leaving group selected from the group  consisting of hydroxy, alkoxy of one to four carbons,  alkoxyalkoxy of two to four carbons, acyloxy of one to  about seven carbon atoms, and trialkylsilyloxy of less then  fifteen carbons;   (d) r₄ is h, hydrocarbyl of one to fourteen carbons, carboxyacyl  of two to twelve carbons, trialkylsilyl of less than  fifteen carbons, and heterocyclic of five to seven atoms  and four to six carbons; and   (e) r5(1) and r5(2) are each h, alkyl of one to eight carbons, or  selected from the group consisting of hydroxy, alkoxy of  one of four carbons, alkoxy-alkoxy of two to four carbons,  trialkylsilyloxy of one to fifteen carbons, cycloalkoxy of  four to eight carbons, carboxyacyloxy of one to seven  carbons, or unsubstituted heterocyclic ether of five to  seven members, with the proviso that at least one of r5(1)  and r5(2) is hydrogen.  a method is disclosed for the cyclisation of the compounds  of formula i leading to novel and biologically active  compounds of the following formulae:  
</ABSTRACT>
</TEXT>
</DOC>
